New Progress of Clinical Application of Nicorandil in the Treatment of Coronary Heart Disease

Abstract

Nicorandil (NIC) is a calcium channel blocker, which has been widely used in the treatment of coronary heart disease (CHD). Although NIC has shown good efficacy and safety clinically, there are still some unresolved issues with its therapeutic mechanism and pathway of action. Studies in recent years have shown that the clinical application of NIC in the treatment of CHD has made new progress, such as being widely used in stable angina pectoris (AP), myocardial infarction, and percutaneous coronary intervention (PCI). In this article, we discuss the new progress of NIC in the treatment of CHD.